Moderna has previously disclosed that the Phase 3 trial of its COVID-19 vaccine candidate mRNA-1273 is expected to begin in July. #pressrelease $MRNA  https://t.co/sYhB32wSax
#businessnews #Oncology #ClinicalTrials #Stocks #COVID19 #vaccine
Picture Credit: MODERNA, INC https://t.co/aQRD35M3xF